- Evaluation of Timeliness of Palivizumab Immunoprophylaxis Based on the Epidemic Period of Respiratory Syncytial Virus: 22 Year Experience in a Single Center
-
Kim SY, Lee KE, Kang SY, Choi EH, Lee HJ
- KMID: 2315682
- Pediatr Infect Vaccine.
- 2015 Dec;22(3):172-177.
- doi: 10.14776/piv.2015.22.3.172
PURPOSE: This study aimed to analyze the epidemic period of RSV infection and evaluate the appropriate time of palivizumab immunoprophylaxis. METHODS: From January 1991 to July 2012, nasopharyngeal (NP) aspirates were... -
- CITED
-
- Close
- SHARE
-
- Close
- Indications, Efficacy and Safety of Anti-RS Virus Monoclonal Antibody Palivizumab (Synagis) for Pediatric Patients With Congenital Heart Diseases
-
Saji BT
- KMID: 2201119
- J Korean Pediatr Cardiol Soc.
- 2007 Sep;11(3):149-150.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Analysis of Palivizumab Prophylaxis in Patients with Acute Lower Respiratory Tract Infection Caused by Respiratory Syncytial Virus
-
Min SJ, Song JS, Choi JH, Seon HS, Kang EK, Kim DH, Kim HS
- KMID: 2278976
- Korean J Pediatr Infect Dis.
- 2011 Dec;18(2):154-162.
PURPOSE: The aim of this study was to identify the clinical characteristics of lower respiratory tract infection due to respiratory syncytial virus (RSV) in young children and to provide information... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Features of Respiratory Syncytial Virus Infection in Neonates: A Single Center Study
-
Chang SH, Jang GC, Yoon SW
- KMID: 2436132
- Neonatal Med.
- 2018 Nov;25(4):144-152.
- doi: 10.5385/nm.2018.25.4.144
PURPOSE: The aim of this study was to investigate the clinical characteristics of Respiratory syncytial virus (RSV) infection during the neonatal period to provide information that is useful in clinical... -
- CITED
-
- Close
- SHARE
-
- Close
- Retrospective Multicenter Study of Respiratory Syncytial Virus Prophylaxis in Korean Children with Congenital Heart Diseases
-
Kim AY, Jung SY, Choi JY, Kim GB, Kim YH, Shim WS, Kang IS, Jung JW
- KMID: 2389631
- Korean Circ J.
- 2016 Sep;46(5):719-726.
- doi: 10.4070/kcj.2016.46.5.719
BACKGROUND AND OBJECTIVES: We conducted a review of current data on respiratory syncytial virus (RSV) prophylaxis with palivizumab, in Korean children with congenital heart diseases (CHD). In 2009, the Korean... -
- CITED
-
- Close
- SHARE
-
- Close
- Seasonal Variations of Respiratory Syncytial Virus Infection among the Children under 60 Months of Age with Lower Respiratory Tract Infections in the Capital Area, the Republic of Korea, 2008-2011
-
Park KH, Shin JH, Lee EH, Seo WH, Kim YK, Song DJ, Choi BM, Choung JT, Hong YS
- KMID: 2188308
- J Korean Soc Neonatol.
- 2012 Nov;19(4):195-203.
- doi: 10.5385/jksn.2012.19.4.195
PURPOSE: Palivizumab prophylaxis has been used in the high risk groups of respiratory syncytial virus (RSV) infections, especially with the prematures, infants with chronic lung diseases or hemodynamically significant congenital... -
- CITED
-
- Close
- SHARE
-
- Close
- Respiratory Syncytial Virus Related Readmission in Preterm Infants Less than 34 weeks' Gestation Following Discharge from a Neonatal Intensive Care Unit in Korea
-
Lee JH, Kim CS, Chang YS, Choi JH, Committee on Data Collection and Statistical Analysis of the Korean Society of Neonatology
- KMID: 2351143
- J Korean Med Sci.
- 2015 Oct;30(Suppl 1):S104-S110.
- doi: 10.3346/jkms.2015.30.S1.S104
This study was done to evaluate respiratory syncytial virus (RSV) related readmission (RRR) and risk factors of RRR in preterm infants < 34 weeks gestational age (GA) within 1 yr... -
- CITED
-
- Close
- SHARE
-
- Close
- Respiratory syncytial virus infection in children with congenital heart disease: global data and interim results of Korean RSV-CHD survey
-
Jung JW
- KMID: 2284867
- Korean J Pediatr.
- 2011 May;54(5):192-196.
- doi: 10.3345/kjp.2011.54.5.192
Respiratory syncytial virus (RSV) is a main cause of hospitalization for bronchiolitis and pneumonia in infants worldwide. Children with hemodynamically significant congenital heart disease (HS-CHD), as well as premature infants... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Synagis(R) (palivizumab) prophylaxis on readmission due to respiratory syncytial virus in very low birth weight infants
-
Park SK, Jung YJ, Yoo HS, Ahn SY, Seo HJ, Choi SH, Kim MJ, Jeon GW, Koo SH, Lee KH, Chang YS, Park WS
- KMID: 2281317
- Korean J Pediatr.
- 2010 Mar;53(3):358-363.
- doi: 10.3345/kjp.2010.53.3.358
PURPOSE: The aim of this study was to determine the efficacy of Synagis(R) (palivizumab) in reducing the respiratory syncytial virus (RSV) readmission rate in very low birth weight infants (VLBWI... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Prophylactic Palivizumab on Admission Due to Respiratory Syncytial Virus Infection in Former Very Low Birth Weight Infants with Bronchopulmonary Dysplasia
-
Han YM, Seo HJ, Choi SH, Jung YJ, Ahn SY, Yoo HS, Sung SI, Shim JW, Lee YK, Ko SY, Shin SM, Hwang JH, Lee JH, Choi BM, Kim ES, Jeon JH, Kim SS, Chang YS, Park WS
- KMID: 2164478
- J Korean Med Sci.
- 2015 Jul;30(7):924-931.
- doi: 10.3346/jkms.2015.30.7.924
The aim of this study was to observe the effects of prophylactic palivizumab on hospitalization secondary to respiratory syncytial virus (RSV) infection (RSVhospitalization) in former very low birth weight infants... -
- CITED
-
- Close
- SHARE
-
- Close
- Respiratory syncytial virus prevention in children with congenital heart disease: who and how?
-
Kim NK, Choi JY
- KMID: 2284868
- Korean J Pediatr.
- 2011 May;54(5):197-200.
- doi: 10.3345/kjp.2011.54.5.197
Respiratory syncytial virus (RSV) is a major cause of respiratory infection in children. Most of the pediatric population have RSV infection before the age of 2, and recurrent infections are... -
- CITED
-
- Close
- SHARE
-
- Close
- Respiratory syncytial virus infection cases in congenital heart disease patients
-
Shim WS, Lee JY, Song JY, Kim SJ, Kim SH, Jang SI, Choi EY
- KMID: 2281320
- Korean J Pediatr.
- 2010 Mar;53(3):380-391.
- doi: 10.3345/kjp.2010.53.3.380
PURPOSE: Respiratory syncytial virus (RSV) is one of the main pathogens causing lower respiratory infections (LRI) in young children, usually of limited severity. However, in congenital heart disease (CHD) patients,... -
- CITED
-
- Close
- SHARE
-
- Close
